Low resistin level is associated with poor hospitalization-free survival in hemodialysis patients

Journal of Korean Medical Science

Volumn 27, Issue 4, 2012, Pages 377-381

  Chung, Wookyung ^a   Jung, Eul Sik ^a   Shin, Dongsu ^a   Choi, Shung Han ^a   Jung, Ji Yong ^a   Chang, Jae Hyun ^a   Lee, Hyun Hee ^a   Kim, Dong Ki ^b   Kim, Sejoong ^a,c  

^a Gachon University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Hospitalization; Renal dialysis; Resistin

Indexed keywords

INTERLEUKIN 6; RESISTIN;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SURVIVAL;

ADULT; AGED; DIABETES COMPLICATIONS; FEMALE; HOSPITALIZATION; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RESISTIN; SURVIVAL ANALYSIS;

EID: 84862879153     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.4.377     Document Type: Article

References (29)

1. Jin DC. Current status of dialysis therapy in Korea. Korean J Intern Med 2011; 26: 123-31.
2. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease: what have we learned in 10 years? Semin Dial 2010; 23: 498-509.
3. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42: 864-81.
4. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-14.
5. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82: 847-50.
6. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-41.
7. Guzik TJ, Mangalat D, Korbut R. Adipocytokines: novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 505-28.
8. Malyszko J, Malyszko JS, Kozminski P, Pawlak K, Mysliwiec M. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. Nephrology (Carlton) 2007; 12: 246-53.
9. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304.
10. Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996; 7: 780-5.
11. Nüsken KD, Kratzsch J, Wienholz V, Stohr W, Rascher W, Dötsch J. Circulating resistin concentrations in children depend on renal function. Nephrol Dial Transplant 2006; 21: 107-12.
12. Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596-604.
13. Liakopoulos V, Mertens PR, Eleftheriadis T, Koukoulis G, Stefanidis I. Is there a link between inflammation, plasma resistin levels, and protein malnutrition in hemodialysis patients? Kidney Int 2006; 70: 1371-2.
14. Fagerberg B, Fagerlund C, Hulthe J. Resistin and GFR. Kidney Int 2006; 70: 1371.
15. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003; 42: 62-6.
16. Mak RH, Cheung W. Adipokines and gut hormones in end-stage renal disease. Perit Dial Int 2007; 27: S298-302.
17. Małgorzewicz S, Aleksandrowicz-Wrona E, Owczarzak A, Debska-Slizień A, Rutkowski B, Łysiak-Szydłowska W. Adipokines and nutritional status for patients on maintenance hemodialysis. J Ren Nutr 2010; 20: 303-8.
18. Wang QY, Zhang H, Yan X, Kang J, Yu RJ. Serum resistin and leptin in patients with chronic obstructive pulmonary disease and their relationship to nutritional state. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28: 445-7.
19. Dostalova I, Kunesova M, Duskova J, Papezova H, Nedvidkova J. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition 2006; 22: 977-83.
20. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
21. Filippidis G, Liakopoulos V, Mertens PR, Kiropoulos T, Stakias N, Verikouki C, Patsidis E, Koukoulis G, Stefanidis I. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif 2005; 23: 421-8.
22. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003; 88: 1730-6.
23. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxic Work Group (EUTox). Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 2010; 77: 550-6.
24. Cohen G, Hörl WH. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Semin Dial 2009; 22: 373-7.
25. Chang JH, Jung JY, Lee HH, Chung W, Joo KW, Kim S. Serum resistin as a novel marker of erythropoietin resistance in nondiabetic patients on hemodialysis. Tohoku J Exp Med 2011; 224: 281-5.
26. Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005; 62: 242-9.
27. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail 2007; 29: 147-54.
28. Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 661-71.
29. Yano A, Nakao K, Sarai A, Akagi S, Kihara T, Morimoto H, Nakamura A, Hiramatsu M, Nagake Y, Makino H. Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis. Nephrology (Carlton) 2005; 10: 576-82.